Analystreport

Nektar Therapeutics (NASDAQ:NKTR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations